Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT

Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Hans Christoph Diener, Ronald E. DeGryse, Richard B. Lipton, Catherine C. Turkel

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint Dive into the research topics of 'Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT'. Together they form a unique fingerprint.

Medicine & Life Sciences

Arts & Humanities